Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Rallybio Community
NasdaqGS:RLYB Community
0
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Community Investing Ideas
Rallybio
Popular
Undervalued
Overvalued
There are no community narratives available.
Your Valuation for
RLYB
RLYB
Rallybio
Your Fair Value
US$
Current Price
US$0.50
63.2% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-94m
14m
2015
2018
2021
2024
2025
2027
2030
Revenue US$13.6m
Earnings US$2.8m
Advanced
Set Fair Value
